Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy

Science Translational Medicine(2023)10.1126/scitranslmed.abq3558Source: DataRank Database

Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy is a research paper published in Science Translational Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 64 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access64 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 6.00)OA: greenTopics (26)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Duo Zhang ORCID,Haowen Jiang ORCID,Jiangbin Ye ORCID,Lin Zhang ORCID,Stephen Bagley ORCID

Live enrichment

PubMed:36791206 PMC:PMC10394757 OpenAlex:https://openalex.org/W4320896693

NINDS NIH HHS

Grant: R01 NS094533

NINDS NIH HHS

Grant: R01 NS106108

NCATS NIH HHS

Grant: UL1 TR001878

NCI NIH HHS

Grant: R01 CA241501

NHLBI NIH HHS

Grant: R01 HL155198

FWCI

6.00

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

green

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10394757/pdf/nihms-1915308.pdf

publisherhttps://www.science.org/doi/pdf/10.1126/scitranslmed.abq3558

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10394757

journalhttps://doi.org/10.1126/scitranslmed.abq3558

Fields of Study

Immune cells in cancerImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

MeSH Terms

AnimalsBrain NeoplasmsGlioblastomaImmunosuppression TherapyImmunotherapyMacrophagesTriterpenesImmunotherapy, AdoptiveCell Line, TumorMiceTumor Microenvironment

Keywords

ImmunotherapyCancer researchImmune systemImmunosuppressionTumor microenvironmentChimeric antigen receptorT cellMacrophageImmunologyDendritic cellMedicineBiology

Sustainable Development Goals

SDG 0: Good health and well-being